News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
ProQuest Associates IV LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/29/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 31,491 shares
@ $41.12, valued at
$1.3M
Sold 177,807 shares
@ $40.51, valued at
$7.2M
|
|
| 11/14/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/20/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/15/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 05/15/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Disposed of 3,584,087 shares
@ $0
Acquired 149,107 shares
@ $0 |
|
| 04/27/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 51,219 shares
@ $88.34, valued at
$4.5M
Sold 2,961 shares
@ $89.09, valued at
$263.8k
Exercised 2,340 options to buy
@ $0.9, valued at
$2.1k
Exercised 2,340 options to buy
@ $4.04, valued at
$9.5k
Exercised 2,340 options to buy
@ $8.78, valued at
$20.5k
Exercised 3,120 options to buy
@ $4.42, valued at
$13.8k
Exercised 9,360 options to buy
@ $12.67, valued at
$118.6k
Exercised 10,000 options to buy
@ $46.09, valued at
$460.9k
Exercised 20,000 options to buy
@ $59.31, valued at
$1.2M
|
|
| 04/03/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 6,223 shares
@ $83, valued at
$516.5k
Sold 23,689 shares
@ $83.02, valued at
$2M
Sold 61,420 shares
@ $83.13, valued at
$5.1M
|
|
| 03/29/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 37,731 shares
@ $83, valued at
$3.1M
Sold 6,182 shares
@ $83.02, valued at
$513.2k
Sold 58,755 shares
@ $83.01, valued at
$4.9M
Sold 400 shares
@ $83, valued at
$33.2k
Sold 500 shares
@ $83.01, valued at
$41.5k
Sold 1,300 shares
@ $83, valued at
$107.9k
Sold 1,600 shares
@ $83.01, valued at
$132.8k
|
|
| 03/23/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 500 shares
@ $83.1, valued at
$41.6k
Sold 700 shares
@ $83.01, valued at
$58.1k
|
|
| 03/20/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 9,120 shares
@ $82.08, valued at
$748.6k
Sold 38,997 shares
@ $82.01, valued at
$3.2M
Sold 51,883 shares
@ $82.1, valued at
$4.3M
|
|
| 02/14/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 01/06/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 65,114 shares
@ $85.16, valued at
$5.5M
|
|
| 11/14/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 15,368 shares
@ $85.1, valued at
$1.3M
Sold 167 shares
@ $86, valued at
$14.4k
Sold 100 shares
@ $86.06, valued at
$8.6k
Sold 1,700 shares
@ $87.05, valued at
$148k
Sold 300 shares
@ $85, valued at
$25.5k
Sold 1,300 shares
@ $85, valued at
$110.5k
Sold 15,551 shares
@ $85, valued at
$1.3M
|
|
| 11/14/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 11/09/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 5,030 shares
@ $75.39, valued at
$379.2k
Sold 1,380 shares
@ $75.7, valued at
$104.5k
Sold 11,690 shares
@ $76.49, valued at
$894.2k
Sold 9,030 shares
@ $77.13, valued at
$696.5k
Sold 4,200 shares
@ $78.23, valued at
$328.6k
Sold 19,581 shares
@ $79.24, valued at
$1.6M
Sold 102,919 shares
@ $80.09, valued at
$8.2M
|
|
| 11/04/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 146,371 shares
@ $70, valued at
$10.2M
Sold 50,329 shares
@ $70.41, valued at
$3.5M
Sold 800 shares
@ $70, valued at
$56k
Sold 2,100 shares
@ $70, valued at
$147k
Sold 46,170 shares
@ $75, valued at
$3.5M
|
|
| 10/04/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 22,100 shares
@ $70.06, valued at
$1.5M
|
|
| 09/30/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 77,900 shares
@ $70.04, valued at
$5.5M
|
|
| 09/23/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 97,149 shares
@ $66.15, valued at
$6.4M
Sold 1,798 shares
@ $67.24, valued at
$120.9k
Sold 194 shares
@ $66.17, valued at
$12.8k
Sold 654 shares
@ $66.17, valued at
$43.3k
|
|
| 09/08/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 12,958 shares
@ $62.45, valued at
$809.2k
Sold 12,224 shares
@ $63.25, valued at
$773.2k
Sold 49 shares
@ $62.83, valued at
$3.1k
Sold 166 shares
@ $62.83, valued at
$10.4k
Sold 11,345 shares
@ $62.26, valued at
$706.3k
Sold 22 shares
@ $62.26, valued at
$1.4k
Sold 75 shares
@ $62.26, valued at
$4.7k
Sold 33,796 shares
@ $62.33, valued at
$2.1M
Sold 66 shares
@ $62.33, valued at
$4.1k
Sold 224 shares
@ $62.33, valued at
$14k
|
|
| 08/25/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 17,118 shares
@ $63.14, valued at
$1.1M
Sold 34 shares
@ $63.12, valued at
$2.1k
Sold 113 shares
@ $63.12, valued at
$7.1k
Sold 11,506 shares
@ $62.78, valued at
$722.3k
Sold 23 shares
@ $62.78, valued at
$1.4k
Sold 76 shares
@ $62.78, valued at
$4.8k
|
|
| 08/17/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 16,667 shares
@ $60.51, valued at
$1M
Sold 8,070 shares
@ $61.31, valued at
$494.8k
Sold 49 shares
@ $60.7, valued at
$3k
Sold 163 shares
@ $60.7, valued at
$9.9k
Sold 16,270 shares
@ $60.66, valued at
$986.9k
Sold 11,770 shares
@ $61.65, valued at
$725.6k
Sold 31,599 shares
@ $62.21, valued at
$2M
Sold 117 shares
@ $60.78, valued at
$7.1k
Sold 394 shares
@ $60.78, valued at
$23.9k
Sold 4,723 shares
@ $60.85, valued at
$287.4k
Sold 9,848 shares
@ $61.19, valued at
$602.6k
|
|
| 08/12/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 06/30/2016 |
4
| ProQuest Financial LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Disposed of 9,903 shares
@ $0 |
|
| 05/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2016 |
4
| ProQuest Management LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 4,000 shares
@ $40, valued at
$160k
Sold 13,980 shares
@ $40.92, valued at
$572.1k
|
|
| 05/13/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/12/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 11/13/2015 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
|
|
|